| Trial ID: | L5133 |
| Source ID: | NCT00576784
|
| Associated Drug: |
Pioglitazone And Glimepiride
|
| Title: |
Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin
|
| Acronym: |
PIOswitch
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Insulin Resistance
|
| Interventions: |
DRUG: pioglitazone and glimepiride
|
| Outcome Measures: |
Primary: The proportion of patients with an increase in HbA1c by 0.5 % after 6 months of treatment compared to baseline HbA1c value, 6 months | Secondary: Absolute change of HbA1c Insulin resistance according to minimal model and HOMA-S analysis change of insulin resistance according to minimal model and HOMA-S analysis to baseline first phase insulin response, 6 months
|
| Sponsor/Collaborators: |
Sponsor: IKFE Institute for Clinical Research and Development
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-04
|
| Completion Date: |
2007-04
|
| Results First Posted: |
|
| Last Update Posted: |
2007-12-19
|
| Locations: |
IKFE, Mainz, 55116, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00576784
|
